Tadeusz Wellisz

Directeur/Membre du Conseil chez ZZ Biotech LLC

Health Technology

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
Joseph J. Romano	M	71	ZZ Biotech LLC ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX.	18 ans
Kent E. Pryor	M	-	ZZ Biotech LLC ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX.	14 ans
Craig M. van de Mark	M	-	ZZ Biotech LLC ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX.	-
Jay Hennock	M	-	ZZ Biotech LLC ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX.	-
Sara Weymer	F	-	ZZ Biotech LLC ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX.	-